DK90090D0 - Fremgangsmaade til fremstilling af naturligt hiv gp160 - Google Patents

Fremgangsmaade til fremstilling af naturligt hiv gp160

Info

Publication number
DK90090D0
DK90090D0 DK090090A DK90090A DK90090D0 DK 90090 D0 DK90090 D0 DK 90090D0 DK 090090 A DK090090 A DK 090090A DK 90090 A DK90090 A DK 90090A DK 90090 D0 DK90090 D0 DK 90090D0
Authority
DK
Denmark
Prior art keywords
procedure
preparation
natural hiv
hiv
natural
Prior art date
Application number
DK090090A
Other languages
English (en)
Other versions
DK175733B1 (da
DK90090A (da
Inventor
Mangalasseril Gop Sarngadharan
Vaniambadi Sriniv Kalyanaraman
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK90090A publication Critical patent/DK90090A/da
Publication of DK90090D0 publication Critical patent/DK90090D0/da
Application granted granted Critical
Publication of DK175733B1 publication Critical patent/DK175733B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Element Separation (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physical Vapour Deposition (AREA)
DK199000900A 1988-08-16 1990-04-10 Fremgangsmåde til fremstilling af naturligt HIV GP160 DK175733B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23285988A 1988-08-16 1988-08-16
US23285988 1988-08-16
US36254889 1989-06-07
US07/362,548 US5116740A (en) 1988-08-16 1989-06-07 Method for producing native hiv gp160
PCT/US1989/003428 WO1990002196A1 (en) 1988-08-16 1989-08-10 Method for producing native hiv gp160
US8903428 1989-08-10

Publications (3)

Publication Number Publication Date
DK90090A DK90090A (da) 1990-04-10
DK90090D0 true DK90090D0 (da) 1990-04-10
DK175733B1 DK175733B1 (da) 2005-02-07

Family

ID=26926401

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199000900A DK175733B1 (da) 1988-08-16 1990-04-10 Fremgangsmåde til fremstilling af naturligt HIV GP160

Country Status (10)

Country Link
US (1) US5116740A (da)
EP (1) EP0394386B1 (da)
KR (1) KR900702045A (da)
AT (1) ATE127526T1 (da)
AU (1) AU638214B2 (da)
DE (1) DE68924155T2 (da)
DK (1) DK175733B1 (da)
FI (1) FI102684B (da)
HK (1) HK1000969A1 (da)
WO (1) WO1990002196A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254457A (en) * 1989-01-11 1993-10-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Monoclonal antibodies and method for identifying different aids-related viruses
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
WO1992006220A1 (en) * 1990-10-05 1992-04-16 President And Fellows Of Harvard College Detection and isolation of ligands
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
US5736317A (en) * 1995-03-07 1998-04-07 Akzo Nobel N.V. Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US20020155120A1 (en) * 1996-07-10 2002-10-24 Lowell George H. Protein and peptide vaccines for inducing mucosal immunity
CN1500806B (zh) * 2002-11-14 2010-05-05 上海科华生物工程股份有限公司 一种HIV－1ɡp160膜蛋白及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
WO1990002567A1 (en) * 1988-09-02 1990-03-22 The Ohio State University Research Foundation Virus-derived antigenic composition and its preparation and use

Also Published As

Publication number Publication date
AU638214B2 (en) 1993-06-24
DK175733B1 (da) 2005-02-07
HK1000969A1 (en) 1998-05-15
FI901879A0 (fi) 1990-04-12
EP0394386A4 (en) 1991-03-13
DE68924155T2 (de) 1996-04-18
US5116740A (en) 1992-05-26
KR900702045A (ko) 1990-12-05
EP0394386A1 (en) 1990-10-31
EP0394386B1 (en) 1995-09-06
WO1990002196A1 (en) 1990-03-08
ATE127526T1 (de) 1995-09-15
DE68924155D1 (de) 1995-10-12
FI102684B1 (fi) 1999-01-29
AU4068789A (en) 1990-03-23
DK90090A (da) 1990-04-10
FI102684B (fi) 1999-01-29

Similar Documents

Publication Publication Date Title
GR3015269T3 (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use.
AU3332089A (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
DK90090D0 (da) Fremgangsmaade til fremstilling af naturligt hiv gp160
ES2032742T1 (es) Un colorante.
NO922953D0 (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
EP0323157A3 (en) Antiviral compounds and methods
ATE123523T1 (de) Expression von hiv1- und 2- polypeptiden und deren verwendung.
EP0184331A3 (en) Psoralen inactivation of human t-cell leukemia virus iii (htlv iii)
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
DK0385909T3 (da) Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
EP0255242A3 (en) Oncornavirus vaccines
DK0555333T3 (da) Kunstige virushylstre
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
NL300073I1 (nl) Vaccin.
ES2174548T3 (es) Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
ZA913909B (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i(hiv-1)gpl20 and methods of use
KR900016262A (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
IT9019153A0 (it) Valvola cardiaca artificiale, con elevatissimo grado di sicurezza
IL90783A0 (en) Antiviral method for human immuno deficiency virus
UA13734A (uk) Спосіб одержаhhя імуhогеhу, який стимулює імуhhу систему людиhи, заражеhої hiv

Legal Events

Date Code Title Description
PUP Patent expired